Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperviscosity syndrome]

T Hashimoto1

  • 1Second Department of Internal Medicine, Teikyo University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Hyperviscosity syndrome, a complication in multiple myeloma patients, causes severe symptoms like bleeding and neurological issues. Plasmapheresis offers rapid improvement by enhancing blood flow dynamics and reducing serum viscosity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[MR imaging evaluation of plica synoviallis mediopatellaris of the knee joint].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy.

Cancer·1992
Same author

Metabolic engineering of medicinal plants: transgenic Atropa belladonna with an improved alkaloid composition.

Proceedings of the National Academy of Sciences of the United States of America·1992
Same author

Protein kinase C-independent sensitization of contractile proteins to Ca2+ in alpha-toxin-permeabilized smooth muscle cells from the guinea-pig stomach.

British journal of pharmacology·1992
Same author

Recurrent annular erythema associated with anti-SS-B/La antibodies: analysis of the disease-specific epitope.

The British journal of dermatology·1992
Same author

Magnetic resonance imaging of the brain structures in the posterior fossa in retarded autistic children.

Acta paediatrica (Oslo, Norway : 1992)·1992
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Nephrology

Context:

  • Hyperviscosity syndrome (HVS) presents with serious clinical manifestations including mucosal bleeding, retinopathy, visual disturbances, and neurological deficits.
  • Multiple myeloma (MM) patients have a 5-10% incidence of HVS due to elevated serum viscosity from myeloma protein.
  • Early recognition and intervention are crucial for managing life-threatening HVS complications.

Purpose:

  • To review the clinical significance of hyperviscosity syndrome in multiple myeloma.
  • To discuss current therapeutic strategies, focusing on plasmapheresis for HVS management.
  • To highlight the role of double filtration plasmapheresis in plasma exchange for MM patients.

Summary:

  • HVS in MM is characterized by increased serum viscosity, leading to significant morbidity and mortality.

Related Experiment Videos

  • Treatment typically involves a combination of plasmapheresis and cytotoxic drugs.
  • Double filtration plasmapheresis is a widely used and effective method for rapid improvement of HVS by reducing plasma volume and viscosity.

    • Impact:

    • Plasmapheresis provides efficient and rapid symptomatic relief in HVS patients.
    • Understanding HVS pathophysiology guides therapeutic decisions in multiple myeloma care.
    • Improved blood flow dynamics post-plasmapheresis contribute to better patient outcomes.